Newsletters
Subscribe
United States
PMI Performance Report: ZYN Soars with 50.3% Surge in US Sales, Marking 4 Consecutive Quarters of Growth
Philip Morris International (PMI) releases Q2 and first half year performance report, showing significant growth in ZYN nicotine pouch sales.
PMI
Jul.25
PMI Delays IQOS Trial in the US, ILUMA to Receive FDA Authorization in 2025
Philip Morris International (PMI) delays US trial sales of IQOS to fourth quarter, lowers annual heated tobacco forecast.
PMI
Jul.25
US E-Cigarette Market Compliance Accelerates: PMTA Approval Rates Rise as Customs Crack Down on Illicit Products
FDA approval of 7 VUSE e-cigarette products follows NJOY's 4, signaling rapid growth in authorized products.
Regulations
Jul.24
PMI Reports Strong Performance for Q2 and First Half2024
PMI announces strong 2024 Q2 and first half results with net income and operating revenue growth.
Jul.24
PMI Q2 Report: ZYN Shipments Surge 50.3% in US, VEEV Take the Lead in 5 European Markets
Philip Morris International (PMI) reports strong Q2 and first half results with net income up 5.6% to $9.5 billion.
PMI
Jul.24
Joe Biden Withdraws to Support Kamala Harris in Presidential Race: Does She Favor Vapes?
U.S. President Joe Biden announces support for VP Kamala Harris to run for President in 2024.
Industry Insight
Jul.23
Smoore International's Client Has 7 Products Authorized by FDA, Stock Surged over 10%
Smoore International (06969.HK) announces approval for seven e-cigarette products by RJ Reynolds Vapor Company through PMTA pathway.
Business
Jul.22
Bat's 7 Vuse Alto E-Cigarettes Receive FDA Marketing Authorization, Boasting Largest PMTA Combination
BAT subsidiary RJ Reynolds Vapor Company's Vuse Alto e-cigarette products receive FDA marketing authorization.
BAT
Jul.19
Load more content
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
sign up
© 2024 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit
https://www.2firsts.cn
English
English
中文
русский язык
español